Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Nicholas Cost

Concepts (400)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Neoplasms
73
2026
419
17.750
Why?
Wilms Tumor
40
2026
91
11.960
Why?
Testicular Neoplasms
24
2026
108
8.860
Why?
Nephrectomy
39
2026
172
7.380
Why?
Neoplasms, Germ Cell and Embryonal
15
2026
76
5.860
Why?
Lymph Node Excision
13
2024
174
3.830
Why?
Carcinoma, Renal Cell
18
2025
231
3.780
Why?
Rhabdoid Tumor
7
2026
99
2.980
Why?
Lower Urinary Tract Symptoms
4
2026
62
2.880
Why?
Neoplasm Staging
31
2026
1488
2.530
Why?
Lymph Nodes
9
2023
511
2.440
Why?
Child
107
2026
22693
2.260
Why?
Urology
8
2024
63
2.230
Why?
Child, Preschool
76
2026
11913
2.100
Why?
Urinary Bladder
5
2024
194
2.060
Why?
Medical Oncology
7
2023
345
1.970
Why?
Urodynamics
4
2025
44
1.890
Why?
Orchiectomy
8
2023
72
1.890
Why?
Laparoscopy
12
2024
487
1.840
Why?
Adolescent
77
2026
22557
1.810
Why?
Infant
64
2026
10114
1.770
Why?
Rhabdomyosarcoma
5
2022
65
1.750
Why?
Hydronephrosis
6
2019
36
1.730
Why?
Urinary Tract
3
2025
47
1.710
Why?
Vincristine
3
2024
148
1.610
Why?
Lymphatic Metastasis
12
2022
335
1.540
Why?
Urologic Surgical Procedures
8
2019
126
1.490
Why?
Urologists
3
2017
20
1.480
Why?
Humans
166
2026
146342
1.430
Why?
Male
115
2026
73396
1.430
Why?
Urologic Neoplasms
4
2017
31
1.430
Why?
Radiotherapy
2
2025
209
1.390
Why?
Prognosis
28
2026
4351
1.340
Why?
Kidney Pelvis
6
2015
22
1.340
Why?
Robotics
6
2015
89
1.320
Why?
Pelvic Neoplasms
3
2025
24
1.310
Why?
Adrenal Gland Neoplasms
3
2022
99
1.310
Why?
Pediatrics
7
2025
1124
1.220
Why?
Practice Patterns, Physicians'
6
2024
1408
1.200
Why?
Urinary Bladder Neoplasms
4
2021
259
1.160
Why?
Organ Sparing Treatments
4
2023
37
1.130
Why?
Ureteral Obstruction
5
2015
62
1.060
Why?
Doxorubicin
2
2021
416
1.050
Why?
Urinary Bladder Diseases
2
2019
18
1.030
Why?
Female
91
2026
79499
1.030
Why?
Kidney
9
2023
1498
1.020
Why?
Retrospective Studies
49
2026
17438
0.980
Why?
Tumor Burden
7
2025
326
0.970
Why?
Neoplasms
8
2026
2954
0.940
Why?
Young Adult
37
2026
14330
0.930
Why?
Kidney Diseases, Cystic
3
2021
24
0.870
Why?
Rhabdomyosarcoma, Embryonal
2
2022
16
0.870
Why?
Nephrons
9
2023
23
0.850
Why?
Biopsy
6
2024
1075
0.830
Why?
Ribonuclease III
3
2021
44
0.820
Why?
Mixed Tumor, Malignant
1
2023
4
0.810
Why?
Sarcoma, Clear Cell
3
2025
10
0.800
Why?
Sertoli-Leydig Cell Tumor
3
2021
8
0.790
Why?
DEAD-box RNA Helicases
3
2021
90
0.780
Why?
Surgeons
4
2025
351
0.770
Why?
Hypospadias
4
2011
34
0.760
Why?
Seminoma
3
2021
20
0.750
Why?
Disease-Free Survival
8
2025
778
0.740
Why?
Age Factors
14
2025
3347
0.730
Why?
Urologic Surgical Procedures, Male
4
2018
33
0.730
Why?
Sarcoma
3
2024
209
0.730
Why?
Leydig Cell Tumor
3
2021
8
0.720
Why?
Spermatic Cord Torsion
2
2013
7
0.720
Why?
Surgical Oncology
2
2025
30
0.700
Why?
Cryptorchidism
2
2019
15
0.690
Why?
Paraganglioma
1
2022
65
0.690
Why?
Pulmonary Blastoma
1
2021
8
0.660
Why?
Tomography, X-Ray Computed
10
2026
2786
0.660
Why?
Lung Neoplasms
5
2026
2675
0.660
Why?
Peripheral Nervous System Diseases
1
2022
135
0.650
Why?
Pheochromocytoma
2
2019
67
0.640
Why?
Survival Rate
14
2026
2092
0.640
Why?
Follow-Up Studies
19
2026
5439
0.640
Why?
Molecular Targeted Therapy
3
2025
447
0.620
Why?
Cancer Survivors
2
2026
348
0.620
Why?
Neoplasms, Muscle Tissue
1
2019
3
0.610
Why?
Neoplasm Recurrence, Local
7
2024
1160
0.610
Why?
Infant, Newborn
11
2023
6460
0.600
Why?
Sex Cord-Gonadal Stromal Tumors
2
2017
5
0.590
Why?
Cystectomy
1
2019
46
0.590
Why?
Smooth Muscle Myosins
1
2019
7
0.590
Why?
Muscle Relaxation
1
2019
28
0.580
Why?
Neoplasm Invasiveness
7
2017
504
0.580
Why?
Myosin Light Chains
1
2019
29
0.580
Why?
Treatment Outcome
28
2026
11821
0.570
Why?
Retroperitoneal Space
2
2024
19
0.570
Why?
Diagnostic Imaging
3
2022
340
0.560
Why?
Fertility Preservation
3
2024
57
0.560
Why?
Surveys and Questionnaires
4
2024
6073
0.550
Why?
Catheterization
1
2019
179
0.550
Why?
Pregnancy Complications, Neoplastic
1
2018
64
0.540
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2026
1998
0.540
Why?
Risk Assessment
12
2026
3712
0.540
Why?
Health Care Surveys
2
2017
541
0.540
Why?
von Hippel-Lindau Disease
1
2018
12
0.540
Why?
Testicular Diseases
1
2018
6
0.540
Why?
Antibiotics, Antineoplastic
1
2019
141
0.540
Why?
Specimen Handling
1
2019
178
0.530
Why?
Calculi
1
2018
15
0.530
Why?
Neoadjuvant Therapy
4
2021
475
0.530
Why?
Tumor Suppressor Protein p53
2
2012
530
0.520
Why?
Orchiopexy
3
2019
6
0.520
Why?
Prospective Studies
12
2026
8123
0.510
Why?
Conservative Treatment
1
2018
45
0.510
Why?
Cause of Death
3
2026
456
0.510
Why?
Kaplan-Meier Estimate
6
2019
970
0.500
Why?
Radiation Exposure
1
2017
62
0.500
Why?
Kidney Medulla
1
2016
28
0.500
Why?
Cytodiagnosis
1
2017
31
0.500
Why?
Critical Pathways
1
2018
104
0.500
Why?
Frozen Sections
1
2017
23
0.490
Why?
Angiomyolipoma
1
2016
21
0.490
Why?
SEER Program
7
2026
233
0.480
Why?
Teratoma
2
2017
121
0.470
Why?
Muscle Contraction
1
2019
438
0.470
Why?
Tuberous Sclerosis
1
2016
56
0.460
Why?
Granuloma, Plasma Cell
1
2015
12
0.460
Why?
Postoperative Care
1
2018
301
0.460
Why?
Survivorship
2
2026
62
0.440
Why?
Pediatricians
1
2016
120
0.440
Why?
Survival Analysis
5
2019
1378
0.440
Why?
Adult
26
2026
41087
0.440
Why?
Glomerular Filtration Rate
4
2018
745
0.440
Why?
Abdominal Neoplasms
2
2025
48
0.430
Why?
Robotic Surgical Procedures
2
2015
210
0.430
Why?
Adenoma
1
2016
210
0.420
Why?
Neurofibromatosis 1
2
2019
59
0.420
Why?
Societies, Medical
5
2025
907
0.410
Why?
Prostatic Neoplasms
2
2019
972
0.410
Why?
Polymorphism, Single Nucleotide
2
2012
2240
0.400
Why?
Hypertension
1
2022
1272
0.400
Why?
Acute-Phase Proteins
1
2013
66
0.390
Why?
Lipocalins
1
2013
35
0.390
Why?
Germ-Line Mutation
3
2025
180
0.390
Why?
Minimally Invasive Surgical Procedures
4
2025
196
0.380
Why?
Ultrasonography
5
2019
788
0.380
Why?
Databases, Factual
5
2019
1493
0.380
Why?
Ovarian Neoplasms
3
2021
604
0.370
Why?
Radiation Protection
1
2013
41
0.370
Why?
United States
16
2026
16136
0.370
Why?
Infertility
2
2024
62
0.370
Why?
Patient Education as Topic
1
2018
770
0.370
Why?
Neoplasms, Radiation-Induced
1
2013
100
0.360
Why?
Combined Modality Therapy
5
2025
1271
0.360
Why?
Biopsy, Needle
1
2013
183
0.360
Why?
Platelet Aggregation Inhibitors
1
2016
499
0.360
Why?
Glucose Transporter Type 1
1
2012
49
0.350
Why?
Carcinoma, Medullary
2
2025
16
0.350
Why?
Multimodal Imaging
1
2013
137
0.340
Why?
Multivariate Analysis
5
2018
1543
0.340
Why?
Neoplasm Metastasis
5
2019
693
0.340
Why?
Codon
1
2011
92
0.330
Why?
Primary Prevention
1
2013
222
0.330
Why?
Incidence
7
2019
2936
0.330
Why?
Proline
1
2011
79
0.330
Why?
Positron-Emission Tomography
1
2013
343
0.330
Why?
Clinical Trials as Topic
2
2026
1064
0.320
Why?
Seasons
1
2013
540
0.310
Why?
Vena Cava, Inferior
1
2011
80
0.310
Why?
Suburethral Slings
1
2010
10
0.310
Why?
Temperature
1
2013
635
0.310
Why?
Arginine
1
2011
264
0.310
Why?
Proto-Oncogene Proteins
1
2013
616
0.300
Why?
Sex Factors
3
2024
2107
0.300
Why?
Hernia, Ventral
1
2010
33
0.300
Why?
Urinary Incontinence
1
2010
65
0.300
Why?
Urinary Bladder, Neurogenic
1
2010
46
0.300
Why?
Creatinine
2
2026
511
0.300
Why?
Mouth Mucosa
1
2009
84
0.290
Why?
Ureter
4
2014
37
0.290
Why?
Campomelic Dysplasia
1
2009
2
0.290
Why?
Dysgerminoma
1
2009
6
0.290
Why?
Urethra
2
2011
55
0.290
Why?
Skin Transplantation
1
2009
77
0.290
Why?
Angiogenesis Inhibitors
1
2011
239
0.290
Why?
Urolithiasis
1
2009
11
0.290
Why?
Clitoris
1
2009
9
0.290
Why?
SOX9 Transcription Factor
1
2009
27
0.280
Why?
Length of Stay
4
2025
1358
0.280
Why?
Brachytherapy
2
2021
132
0.280
Why?
Recovery of Function
1
2013
725
0.280
Why?
Bone Neoplasms
1
2011
272
0.280
Why?
Venous Thrombosis
1
2011
199
0.280
Why?
Surgical Flaps
1
2009
140
0.270
Why?
Time Factors
8
2019
7109
0.270
Why?
Attitude of Health Personnel
1
2016
1219
0.270
Why?
Acute Kidney Injury
1
2015
866
0.260
Why?
Aged
12
2025
26432
0.250
Why?
Calcinosis
1
2009
231
0.250
Why?
Neuroblastoma
2
2025
177
0.250
Why?
Middle Aged
14
2025
36619
0.240
Why?
Nerve Growth Factor
1
2026
36
0.240
Why?
Health Promotion
1
2013
786
0.240
Why?
Risk Factors
8
2018
10921
0.240
Why?
Ureterocele
2
2016
7
0.230
Why?
Brain-Derived Neurotrophic Factor
1
2026
155
0.220
Why?
Vesico-Ureteral Reflux
2
2016
38
0.220
Why?
Postoperative Complications
6
2025
3034
0.220
Why?
Mitotic Index
2
2015
24
0.220
Why?
Biomarkers, Tumor
3
2025
1339
0.220
Why?
Carcinoma, Papillary
1
2025
83
0.220
Why?
Kidney Diseases
1
2009
428
0.210
Why?
Hypertrophy
2
2019
127
0.210
Why?
Antineoplastic Agents
3
2025
2219
0.210
Why?
Protein Kinase Inhibitors
1
2011
983
0.210
Why?
Genetic Predisposition to Disease
5
2025
2488
0.210
Why?
Perioperative Care
2
2024
235
0.210
Why?
Chemotherapy, Adjuvant
4
2013
429
0.200
Why?
Adenosine Triphosphate
1
2026
494
0.200
Why?
Clinical Competence
2
2025
1272
0.190
Why?
Gonadal Dysgenesis
1
2023
6
0.190
Why?
Adrenal Cortex Neoplasms
1
2024
70
0.190
Why?
Adrenocortical Carcinoma
1
2024
72
0.190
Why?
Antineoplastic Agents, Phytogenic
1
2024
178
0.190
Why?
Lymphocytes
1
2025
379
0.190
Why?
Tumor Suppressor Proteins
1
2025
315
0.190
Why?
Mast Cells
1
2024
150
0.190
Why?
Pubic Bone
1
2022
6
0.180
Why?
Adaptor Proteins, Signal Transducing
1
2025
429
0.180
Why?
Monocytes
1
2025
538
0.180
Why?
Urination
1
2022
46
0.170
Why?
Algorithms
1
2009
1849
0.170
Why?
Blood Platelets
1
2025
382
0.170
Why?
Sertoli Cell Tumor
1
2021
1
0.170
Why?
Sentinel Lymph Node Biopsy
1
2022
118
0.170
Why?
Biomarkers
3
2026
4340
0.170
Why?
Retroperitoneal Neoplasms
1
2021
28
0.170
Why?
Aniridia
1
2020
5
0.160
Why?
Diagnosis, Differential
3
2019
1503
0.160
Why?
PAX6 Transcription Factor
1
2020
21
0.160
Why?
Testosterone
2
2015
419
0.160
Why?
Interleukin-2
1
2022
434
0.160
Why?
Neoplastic Syndromes, Hereditary
1
2021
47
0.160
Why?
Pneumothorax
1
2021
54
0.160
Why?
Codon, Nonsense
1
2020
46
0.160
Why?
Positron Emission Tomography Computed Tomography
2
2019
122
0.160
Why?
Feasibility Studies
3
2026
1135
0.160
Why?
Eye Proteins
1
2020
93
0.160
Why?
Reoperation
3
2014
645
0.160
Why?
Priapism
1
2019
9
0.150
Why?
Penile Neoplasms
1
2019
7
0.150
Why?
Syndrome
1
2021
380
0.150
Why?
Dose-Response Relationship, Drug
1
2024
2022
0.150
Why?
Chemoradiotherapy, Adjuvant
1
2019
44
0.150
Why?
Patient Selection
3
2013
728
0.150
Why?
Myosin-Light-Chain Kinase
1
2019
19
0.150
Why?
Large-Conductance Calcium-Activated Potassium Channel beta Subunits
1
2019
8
0.150
Why?
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits
1
2019
10
0.150
Why?
Proportional Hazards Models
3
2011
1331
0.140
Why?
Neutrophils
1
2025
1133
0.140
Why?
Decision Trees
1
2019
76
0.140
Why?
Computers
1
2019
66
0.140
Why?
Puberty, Precocious
1
2019
12
0.140
Why?
Genotype
2
2016
1879
0.140
Why?
Dermatofibrosarcoma
1
2018
7
0.140
Why?
Hospitals
1
2023
738
0.140
Why?
Genetic Testing
2
2019
492
0.140
Why?
Self-Examination
1
2018
1
0.140
Why?
Diagnostic Errors
1
2019
178
0.130
Why?
Chemoradiotherapy
1
2019
238
0.130
Why?
Proton Therapy
1
2018
16
0.130
Why?
Animals
6
2025
38107
0.130
Why?
Radiotherapy, Adjuvant
1
2018
222
0.130
Why?
Tertiary Care Centers
1
2019
196
0.130
Why?
Analysis of Variance
2
2017
1298
0.130
Why?
Mutation
1
2009
4093
0.130
Why?
Preoperative Period
1
2018
157
0.130
Why?
Asymptomatic Diseases
1
2018
102
0.130
Why?
Drug Utilization
1
2018
171
0.130
Why?
Aged, 80 and over
4
2019
8391
0.130
Why?
Unnecessary Procedures
1
2017
56
0.130
Why?
Testis
1
2018
158
0.130
Why?
Registries
3
2025
2400
0.130
Why?
Ultrasonography, Doppler
1
2018
122
0.130
Why?
Pancreatic Neoplasms
1
2025
944
0.120
Why?
Intraoperative Period
1
2017
69
0.120
Why?
Europe
1
2018
421
0.120
Why?
General Surgery
1
2019
217
0.120
Why?
Logistic Models
3
2018
2126
0.120
Why?
Mice
3
2024
18297
0.120
Why?
Mice, Inbred BALB C
1
2019
1244
0.120
Why?
Health Knowledge, Attitudes, Practice
1
2025
1408
0.120
Why?
Feminization
1
2015
6
0.120
Why?
North America
1
2016
300
0.110
Why?
Fellowships and Scholarships
1
2019
355
0.110
Why?
Certification
1
2016
118
0.110
Why?
Translocation, Genetic
2
2018
127
0.110
Why?
Pregnancy Outcome
1
2018
503
0.110
Why?
Models, Statistical
1
2019
669
0.110
Why?
Learning
1
2019
446
0.110
Why?
Practice Guidelines as Topic
2
2020
1591
0.110
Why?
Phosphorylation
1
2019
1724
0.110
Why?
History, 21st Century
1
2015
224
0.110
Why?
Anaplasia
2
2024
7
0.100
Why?
Matched-Pair Analysis
1
2014
38
0.100
Why?
Forecasting
1
2016
388
0.100
Why?
Adrenergic alpha-1 Receptor Antagonists
1
2014
18
0.100
Why?
Genitalia, Female
1
2014
43
0.100
Why?
TRPM Cation Channels
1
2014
74
0.100
Why?
Ureteral Calculi
1
2014
15
0.100
Why?
Kidney Function Tests
1
2014
156
0.100
Why?
Inflammation
1
2025
2919
0.100
Why?
Statistics, Nonparametric
1
2014
426
0.100
Why?
Disease Management
1
2017
651
0.100
Why?
Lipocalin-2
1
2013
80
0.090
Why?
Delivery of Health Care
1
2020
947
0.090
Why?
Estrogens
1
2015
364
0.090
Why?
Blood Vessels
1
2014
164
0.090
Why?
Magnetic Resonance Imaging
3
2021
3926
0.090
Why?
Tissue Array Analysis
1
2012
49
0.090
Why?
Spermatic Cord
1
2012
1
0.090
Why?
Monitoring, Physiologic
1
2014
279
0.090
Why?
Autophagy
1
2014
290
0.090
Why?
Cohort Studies
5
2016
6077
0.090
Why?
Immunoenzyme Techniques
1
2012
197
0.090
Why?
Radiation Dosage
1
2013
193
0.090
Why?
Skin Neoplasms
1
2018
806
0.080
Why?
Fetal Diseases
1
2013
192
0.080
Why?
Surgical Wound Dehiscence
1
2011
22
0.080
Why?
Carcinoma, Transitional Cell
1
2011
70
0.080
Why?
Cross-Sectional Studies
2
2014
5899
0.080
Why?
Thrombectomy
1
2011
79
0.080
Why?
Bevacizumab
1
2011
169
0.080
Why?
Compliance
1
2010
50
0.080
Why?
Texas
1
2011
280
0.080
Why?
Rectum
1
2011
180
0.080
Why?
Chi-Square Distribution
1
2011
517
0.080
Why?
Sulfonamides
1
2014
594
0.080
Why?
Pyrroles
1
2011
222
0.070
Why?
Referral and Consultation
1
2016
881
0.070
Why?
Muscle, Smooth
1
2010
152
0.070
Why?
Penis
2
2019
33
0.070
Why?
Operative Time
3
2014
195
0.070
Why?
Polymerase Chain Reaction
1
2012
1031
0.070
Why?
Drug Administration Schedule
1
2011
790
0.070
Why?
Internship and Residency
1
2019
1281
0.070
Why?
Radiography
1
2011
861
0.070
Why?
Remission, Spontaneous
2
2021
39
0.070
Why?
Alleles
1
2011
907
0.070
Why?
Pilot Projects
1
2014
1888
0.070
Why?
MicroRNAs
1
2014
699
0.070
Why?
Congenital Abnormalities
1
2008
108
0.060
Why?
Predictive Value of Tests
1
2013
2113
0.060
Why?
Indoles
1
2011
511
0.060
Why?
Case-Control Studies
1
2014
3647
0.060
Why?
Kidney Failure, Chronic
1
2012
589
0.060
Why?
Severity of Illness Index
1
2014
2921
0.060
Why?
Pregnancy
1
2018
7230
0.060
Why?
Signal Transduction
1
2019
5246
0.060
Why?
Cystoscopy
2
2016
21
0.060
Why?
Nephroma, Mesoblastic
1
2025
2
0.060
Why?
Biopsy, Large-Core Needle
1
2024
15
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2011
992
0.050
Why?
Image-Guided Biopsy
1
2024
41
0.050
Why?
Adrenalectomy
1
2024
68
0.050
Why?
Nephroureterectomy
1
2023
2
0.050
Why?
Antibodies, Monoclonal
1
2011
1512
0.050
Why?
Sexual Development
1
2023
17
0.050
Why?
Gonads
1
2023
23
0.050
Why?
Delphi Technique
1
2025
350
0.050
Why?
Lymphoma
1
2024
251
0.050
Why?
Pancreatectomy
1
2025
289
0.050
Why?
Analgesics, Opioid
2
2024
1221
0.040
Why?
Germany
1
2020
139
0.040
Why?
Accreditation
1
2019
100
0.040
Why?
Hyperplasia
1
2019
164
0.040
Why?
Mohs Surgery
1
2018
30
0.030
Why?
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
1
2018
28
0.030
Why?
Liver Neoplasms
1
2024
776
0.030
Why?
Mosaicism
1
2017
67
0.030
Why?
In Situ Hybridization, Fluorescence
1
2018
334
0.030
Why?
Ureteroscopy
1
2016
16
0.030
Why?
Monitoring, Intraoperative
1
2016
66
0.030
Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2014
19
0.030
Why?
Caveolin 1
1
2014
20
0.030
Why?
Education, Medical, Graduate
1
2019
568
0.030
Why?
Ureterostomy
1
2014
3
0.030
Why?
Neoplasm Transplantation
1
2014
238
0.030
Why?
Oncogenes
1
2014
113
0.030
Why?
Bone Marrow Neoplasms
1
2013
4
0.020
Why?
Cicatrix
1
2014
72
0.020
Why?
Organ Size
1
2014
465
0.020
Why?
Mice, Nude
1
2014
668
0.020
Why?
RNA Interference
1
2014
472
0.020
Why?
HEK293 Cells
1
2014
750
0.020
Why?
Comparative Genomic Hybridization
1
2011
28
0.020
Why?
Neoplasm Grading
1
2011
313
0.020
Why?
Area Under Curve
1
2011
335
0.020
Why?
Sensitivity and Specificity
1
2015
1998
0.020
Why?
Gene Silencing
1
2011
200
0.020
Why?
Quality of Life
1
2022
3200
0.020
Why?
Preoperative Care
1
2012
396
0.020
Why?
Dihydrolipoamide Dehydrogenase
1
2009
6
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2014
1432
0.020
Why?
Cell Line, Tumor
1
2014
3545
0.020
Why?
Cost's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)